Vascular &
Endovascular Surgery
Our Programs ABOUT US News

harris
We provide expert care for patients with complex aortic, arterial and venous disorders.

Patient Scheduling and Consultation Services

Basic, translational and applied research into all facets of vascular disease.

Stanford Cardiovascular Institute: 2013-2014 Report.

New Partnership
Stanford Vascular Surgery and Santa Clara Valley Medical Center Beginning 3.1.15 

 

Welcome to Stanford Vascular and Endovascular Surgery. We are dedicated to the highest levels of patient care, professional education and clinical and translational research.

Ronald L. Dalman, MD Chidester Professor

and Division Chief of Vascular Surgery


The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.

The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.

2014 Faculty and Residents

 

Dr. Wei Zhou has been appointed to the Program Committee of the Western Vascular Society. Dr. Zhou's appointment extends the influence of the Stanford faculty on the WVS - Dr. Jason Lee is completing his fourth year on the Committee as Chair in 2015, and Dr. E. John Harris completed his three year assignment as WVS Secretary at the 2014 meeting in San Diego. Drs. Dalman and Olcott (Professor Emeritus of Surgery at Stanford) are Past Presidents of the WVS >>> (Dec. 17, 2014)

The T32 training grant Mechanisms and Innovation in Vascular Disease co-directed by Dr. Ronald Dalman and Dr. Phil Tsao has been renewed from 2015 to 2020. This program provides mentored research training in vascular disease research managed through the Stanford Cardiovascular Institute . Our Integrated Vascular Surgery Residency includes two years as a CVI T32 fellow, with the ability to work in almost any research field related to vascular biology, vascular disease management, or population health >>> (Dec. 1, 2014)

The Leeper lab receives an NIH R01 to study the genetic determinants of angiogenesis in peripheral vascular disease. The title of this R01 is The paradoxical role of CDKN2B in blood vessel sprouting and maturation >>> (Nov. 19, 2014)

Stanford Health Care Opens Advanced Wound Care Center >>> (Oct. 21, 2014)

More News   

Stanford Medicine Resources:

Footer Links: